bavisant (JNJ-31001074) / J&J, BenevolentAI - LARVOL DELTA

CASPAR: BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness (clinicaltrials.gov) - P2 | N=244 | Completed | Sponsor: BenevolentAI Bio | Phase classification: P2b ➔ P2

Phase classification • CNS Disorders • Excessive Daytime Sleepiness • Movement Disorders • Parkinson's Disease • Sleep Disorder

"Ben 2001 mezunuyum." (@FFTB9501)

Histamine receptors, agonists, and antagonists in health and disease. (PubMed, Handb Clin Neurol) - "Pitolisant, a H3 receptor antagonist, is used to treat narcolepsy and hypersomnia...H2 receptor antagonists have shown efficacy in treatment of schizophrenia, but they are not in widespread clinical use. H4 receptor ligands may in the future be tested for neuroimmunological disorders and potentially neurodegenerative disorders in which inflammation plays a role, but clinical tests have not yet been initiated."

Journal • Allergy • CNS Disorders • Immunology • Inflammation • Insomnia • Narcolepsy • Peptic Ulcer • Psychiatry • Schizophrenia • Sleep Disorder